Perspective Therapeutics annual gross margin
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Perspective Therapeutics Gross Margin Growth & History (CATX)
Perspective Therapeutics's gross margin was 100.00% for fiscal 2023.
View full Perspective Therapeutics company overviewPerspective Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 100.00% | — |
| 2022 · Jun 30 | 2022-06-30 | 0.00% | −50.94 pp |
| 2021 | 2021-06-30 | 50.94% | −1.99 pp |
| 2020 | 2020-06-30 | 52.93% | +11.27 pp |
| 2019 | 2019-06-30 | 41.66% | +10.56 pp |
| 2018 | 2018-06-30 | 31.10% | +13.50 pp |
| 2017 | 2017-06-30 | 17.60% | +14.90 pp |
| 2016 | 2016-06-30 | 2.70% | −0.92 pp |
| 2015 | 2015-06-30 | 3.63% | +8.28 pp |
| 2014 | 2014-06-30 | −4.66% | −7.98 pp |
| 2013 | 2013-06-30 | 3.32% | −10.55 pp |
| 2012 | 2012-06-30 | 13.87% | −8.23 pp |
| 2011 | 2011-06-30 | 22.09% | — |
Perspective Therapeutics quarterly gross margin
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q1.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-09-30 | 38.66% | +14.55 pp |
| Q2 2023 | 2023-06-30 | 16.53% | −20.43 pp |
| Q1 2023 · Mar 31 | 2023-03-31 | 26.61% | −22.91 pp |
| Q1 2023 · Sep 30 | 2022-09-30 | 24.11% | −16.02 pp |
| Q4 2022 | 2022-06-30 | 36.97% | −12.70 pp |
| Q3 2022 | 2022-03-31 | 49.52% | −2.87 pp |
| Q2 2022 | 2021-12-31 | 43.32% | −6.15 pp |
| Q1 2022 | 2021-09-30 | 40.13% | −12.13 pp |
| Q4 2021 | 2021-06-30 | 49.67% | +2.67 pp |
| Q3 2021 | 2021-03-31 | 52.38% | −6.85 pp |
| Q2 2021 | 2020-12-31 | 49.47% | −0.89 pp |
| Q1 2021 | 2020-09-30 | 52.27% | −1.13 pp |
| Q4 2020 | 2020-06-30 | 46.99% | +1.31 pp |
| Q3 2020 | 2020-03-31 | 59.24% | +13.55 pp |
| Q2 2020 | 2019-12-31 | 50.36% | +10.18 pp |
| Q1 2020 | 2019-09-30 | 53.39% | +19.84 pp |
| Q4 2019 | 2019-06-30 | 45.69% | +18.05 pp |
| Q3 2019 | 2019-03-31 | 45.69% | +6.97 pp |
| Q2 2019 | 2018-12-31 | 40.18% | +5.61 pp |
| Q1 2019 | 2018-09-30 | 33.55% | +11.66 pp |
| Q4 2018 | 2018-06-30 | 27.64% | −8.71 pp |
| Q3 2018 | 2018-03-31 | 38.72% | +15.86 pp |
| Q2 2018 | 2017-12-31 | 34.57% | +34.67 pp |
| Q1 2018 | 2017-09-30 | 21.88% | +17.44 pp |
| Q4 2017 | 2017-06-30 | 36.35% | +40.64 pp |
| Q3 2017 | 2017-03-31 | 22.85% | +17.35 pp |
| Q2 2017 | 2016-12-31 | −0.10% | −2.62 pp |
| Q1 2017 | 2016-09-30 | 4.44% | −2.14 pp |
| Q4 2016 | 2016-06-30 | −4.29% | −19.57 pp |
| Q3 2016 | 2016-03-31 | 5.51% | +0.74 pp |
| Q2 2016 | 2015-12-31 | 2.52% | +6.09 pp |
| Q1 2016 | 2015-09-30 | 6.58% | +11.84 pp |
| Q4 2015 | 2015-06-30 | 15.29% | +29.63 pp |
| Q3 2015 | 2015-03-31 | 4.77% | +0.28 pp |
| Q2 2015 | 2014-12-31 | −3.56% | −0.44 pp |
| Q1 2015 | 2014-09-30 | −5.26% | +2.10 pp |
| Q4 2014 | 2014-06-30 | −14.34% | −25.88 pp |
| Q3 2014 | 2014-03-31 | 4.49% | −10.37 pp |
| Q2 2014 | 2013-12-31 | −3.12% | +13.14 pp |
| Q1 2014 | 2013-09-30 | −7.36% | −5.43 pp |
| Q4 2013 | 2013-06-30 | 11.54% | −6.28 pp |
| Q3 2013 | 2013-03-31 | 14.85% | −0.65 pp |
| Q2 2013 | 2012-12-31 | −16.26% | −32.45 pp |
| Q1 2013 | 2012-09-30 | −1.93% | −7.40 pp |
| Q4 2012 | 2012-06-30 | 17.82% | −18.52 pp |
| Q3 2012 | 2012-03-31 | 15.50% | −9.83 pp |
| Q2 2012 | 2011-12-31 | 16.19% | +5.91 pp |
| Q1 2012 | 2011-09-30 | 5.47% | −10.78 pp |
| Q4 2011 | 2011-06-30 | 36.34% | — |
| Q3 2011 | 2011-03-31 | 25.34% | — |
| Q2 2011 | 2010-12-31 | 10.28% | — |
| Q1 2011 | 2010-09-30 | 16.25% | — |
Perspective Therapeutics gross margin trends
Between the periods ended 2011-06-30 and 2023-12-31, Perspective Therapeutics's gross margin increased from 22.09% to 100.00%, a change of +77.91 percentage points. The latest reported quarter, Q3 2023, shows 38.66%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Perspective Therapeutics source filings ↗